Skip to main content


The Long Covid Cutaneous Signatures (LCCS) Study:
Help Advance Important Clinical Research

You may qualify:

  • If you have been previously diagnosed with COVID-19 (i.e., through a positive test result) and you no longer are experiencing any symptoms
  • If you have been previously diagnosed with COVID-19 and continue to experience symptoms of Long COVID that has persisted for at least 3 months

What is expected from you to participate in the study?

  • Complete a 2-3 hour in-person interview
  • 3 small skin biopsies will be collected by a healthcare professional

You’ll earn $250 for participating!

Call 480-569-2902 to learn more about participating in the study or fill out the form below and we will contact you.

Participate in our Research Study! Dec 11, 2023

  • About the Clinical Study

    The Long COVID Cutaneous Signature Study (LCCS) is sponsored by CND Life Sciences through an American Rescue Plan Act (ARPA) grant through the State of Arizona.

    CND is a leader in cutaneous neurodiagnostics, pioneering innovative science that enables the detection and visualization of abnormal proteins and other pathological markers in the nerves of the skin. Results from CND's diagnostic testing help clinicians and patients understand potential signs and pathways of certain neurological disorders and can assist in the development of new treatments.